FDA limits use of Johnson & Johnson COVID vaccine due to risk of life-threatening blood clots

The Food and Drug Administration announced Thursday it will restrict the use of the Johnson & Johnson one-shot COVID-19 vaccine after an investigation revealed that those who got the jab were at increased risk of developing life-threatening blood clots. 

The agency is now only authorizing the pharmaceutical giant's Janssen COVID vaccine to people 18 or older for whom other authorized or approved vaccines are not accessible or clinically appropriate, and to those 18 years or older who otherwise would not get a COVID vaccine.

MORE

-Robert